TrialEuropean journal of heart failure2020

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).

Kevin Damman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.